; or (2) the Secretary of Veterans Affairs determines that access to the drug is essential to the health of beneficiaries under the laws administered by the Secretary. . (b) Clerical amendment The table of sections at the beginning of such subchapter is amended by inserting after the item relating to section 8126 the following new item: 8126A. Procurement of generic drugs manufactured domestically. . (c) Effective date The amendments made by this section shall take effect on January 1, 2025. 7. Procurement by Department of Defense of generic drugs manufactured domestically (a) In general Chapter 55 of title 10, United States Code, is amended by inserting after section 1074g the following new section: 1074g–1. Procurement of generic drugs manufactured domestically (a) In general Subject to subsection (b), the Secretary of Defense may only procure a generic drug if it is a generic drug manufactured domestically, as described in section 2(b) of the Accelerating Movement of Essential Rx Items to Create Access to National Drug Resources for US Government Services Act . (b) Exceptions Subsection (a) shall not apply with respect to a drug during any period for which— (1) the Secretary of Health and Human Services has notified the Secretary of Defense pursuant to section 2(a) of the Accelerating Movement of Essential Rx Items to Create Access to National Drug Resources for US Government Services Act that the circumstances under paragraph (2), (3), or (4) of such section apply; or (2) the Secretary of Defense determines that access to the drug is essential to the health of beneficiaries under the TRICARE program. . (b) Clerical amendment The table of sections at the beginning of such chapter is amended by inserting after the item relating to section 1074g the following new item: 1074g–1. Procurement of generic drugs manufactured domestically. . (c) Effective date The amendments made by this section shall take effect on January 1, 2025.